Menu Back toSpeakers

DIA Annual Canadian Meeting


Speakers

  • Fiona  Frappier, PhD

    Fiona Frappier, PhD

    • Senior Policy Analyst
    • Health Canada, Canada

    Fiona Frappier is a Senior Policy Analyst at the Biologics and Genetic Therapies Directorate of the Health Products Food Branch. Fiona supports Branch work in applying the Canadian Food and Drug Act and Regulations by developing Guidance to Sponsors regarding submission requirements for clinical trial applications and new drug submissions. Previous work experience includes policy development and coordination, public health system design and transformation, fostering research and stakeholder engagement. Prior to joining BGTD Fiona has worked with Health Canada and the Public Health Agency of Canada on multi-jurisdictional policy issues such as climate change, antimicrobial resistance and genomics.

  • Melissa  Hunt, MSc

    Melissa Hunt, MSc

    • Acting Director
    • Health Canada, Canada

    Melissa Hunt joined Health Canada in 2005. She holds a Bachelor of Science in Life Sciences from Queen’s University and a Master of Science in Pharmacology from the University of Toronto. Prior to working at Health Canada, Melissa worked for several years within the pharmaceutical industry. At Health Canada she has worked as a Scientific Evaluator and a Manager in the Marketed Pharmaceuticals and Medical Devices Bureau within MHPD, as well as on the core team Health Products and Food Branch "Regulatory Review of Drugs and Devices" initiative. Most recently she has taken a position as the Interim Director of the Bureau of Metabolism, Oncology and Reproductive Sciences within the Therapeutic Products Directorate.

  • Yatika  Kohli, PhD, MBA

    Yatika Kohli, PhD, MBA

    • Executive Director - Global Regulatory Affairs
    • NoNO Inc, Canada

    Dr. Yatika Kohli is a candid professional of strategic foresight & business acumen with over 15 years of experience in leading Research to Launch activities in a fast-paced, high growth environment at global bio-pharma companies. She has expertise in developing global regulatory & clinical strategy of biologics and biosimilar products with project management experience across several therapeutic areas and technical initiatives. She has registered 2 US vaccines at Sanofi Pasteur and 1 EU biosimilar at Apotex. Currently as VP of Regulatory Affairs and Project Office at Medicago, she is working on development and registration of plant-derived influenza vaccine.

  • Rania  Mouchantaf, PhD

    Rania Mouchantaf, PhD

    • Manager
    • Marketed Health Product Directorate, Health Canada, Canada

    Dr. Rania Mouchantaf has over 10 years of experience in the area of pharmacovigilance and drug safety. In addition to her role as manager, Dr. Mouchantaf has led the standardization of the risk management planning process in Canada and is actively involved in the regulatory modernization of other various pre and post-market processes. Before entering the government Dr. Mouchantaf worked in the area of business development at Paladin labs in Montreal. Her education includes a Bachelor degree in Microbiology and Immunology and a doctorate degree in Pharmacology and Therapeutics from McGill University. She also completed a post-doctoral fellowship at the University of Montreal in the area of oncology and breast cancer-research.

  • Marc F. Poitras, PhD, MBA

    Marc F. Poitras, PhD, MBA

    • Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
    • Health Canada, Canada

    Dr. Poitras has worked at Health Canada in different capacities in Pharmacovigilance and drug safety for the last 10 years. His undergraduate and graduate training includes a BSc in Biotechnology and MSc/PhD degrees in Pharmacology from the University of Sherbrooke. He also completed post-doctoral training programs in cellular biology and neuroscience at Johns Hopkins University and New York University. He then completed a MBA at the University of Ottawa. Dr. Poitras is currently working as a Scientific Manager at the Marketed Health Products Directorate.

  • Kristin  Willemsen, MS

    Kristin Willemsen, MS

    • Director of Scientific & Regulatory Affairs
    • Consumer Health Products Canada, Canada

    Kristin Willemsen is the Director of Scientific and Regulatory Affairs for Consumer Health Products Canada. Since 2008, she has been working with members to influence the regulation of over-the-counter drugs and natural health products. Kristin earned a Masters of Science from the University of Ottawa and is a Certified Association Executive.

  • Jennifer  Chan, MSc

    Jennifer Chan, MSc

    • Vice President, Policy and External Affairs
    • Merck Canada Inc., Canada

  • Robin  Churchill

    Robin Churchill

    • Health Canada, Canada

  • Loretta  Del Bosco

    Loretta Del Bosco

    • Director, Regulatory Affairs Quality Assurance Operations
    • AbbVie Corporation, Canada

    Loretta has spent several decades in the Canadian pharmaceutical industry and is the current Director, Regulatory Affairs, Quality Assurance and Operations, AbbVie Canada, the Vice-Chair of Canada’s Innovative Medicines Canada Regulatory Affairs Committee and member of BIOTECanada’s Subsequent Entry Biologics Committee and Biologics Regulatory Affairs Group. A member of the McGill University Faculty of Science Advisory Board and Microbiology and Immunology McGill graduate.

  • Lorella  Garofalo, PhD

    Lorella Garofalo, PhD

    • Director, Regulatory Affairs; Worldwide Safety and Regulatory-Innovative
    • Pfizer Canada Inc, Canada

    Lorella has been with Pfizer Canada since 2001 assuming roles of increasing responsibility in clinical research as well as medical affairs and is currently head of regulatory affairs for Pfizer’s Innovative business. She obtained a BSc (Honours) in Biochemistry and a PhD in Pharmacology & Therapeutics from McGill University. Prior to joining Pfizer, Lorella was a drug assessment officer at TPD, Health Canada and since 1999 has maintained an academic appointment with the department of Pharmacology & Therapeutics at McGill. She has served as a member of the board of directors/advisory councils for various research organizations and is a member of the regulatory affairs committees of Innovative Medicines Canada and BIOTECanada.

Contact us

Registration Questions?

Send Email
1.888.257.6457